Review ArticleSystematic Review
Open Access

Celiac disease in type 1 diabetes mellitus in the Kingdom of Saudi Arabia

Characterization and meta-analysis

Mohammad-Ayman A. Safi
Saudi Medical Journal July 2019, 40 (7) 647-656; DOI: https://doi.org/10.15537/smj.2019.7.24293

Article Figures & Data

Figures

  • Figure 1
    Figure 1

    PRISMA flow-diagram showing the selection process of the pertinent studies. CD- celiac diseases, KSA - Kingdom of Saudi Arabia, T1DM - type 1 diabetes mellitus.

  • Figure 2
    Figure 2

    Sample size and prevalence (seropositivity rate and biopsy-proven rate) of celiac disease among type 1 diabetes mellitus patients in the retrieved studies. Al-Ashwal AA et al 200310 (1), Saadah OI et al 200411 (2), Al-Hussaini A et al 201212 (3), Saadah OI et al 201213 (4), Al-Agha AE et al 201514 (5), Al-Hakami AM 201616 (6), Alshareef MA et al 201615 (only seropositivity rate) (7), Alghamdi RA et al 201817 (only seropositivity rate) (8).

  • Figure 3
    Figure 3

    Seroprevalence (by fixed and random models) with statistics and relative weight for each study.

  • Figure 4
    Figure 4

    Forest plot for prevalence of seropositive celiac diseases among type one diabetes mellitus in the Kingdom of Saudi Arabia.

  • Figure 5
    Figure 5

    Prevalence of biopsy-proven CD (by fixed and random models) with statistics and relative weight for each study. CD- celiac diseases, KSA - Kingdom of Saudi Arabia, T1DM - type 1 diabetes mellitus.

  • Figure 6
    Figure 6

    Forest plot for prevalence of biopsy-proven celiac disease among type 1 diabetes mellitus in Saudi Arabia. CI - confidence interval

Tables

  • Table 1
  • Table 2
  • Table 3
  • Table 4
  • Table 5
  • Table 6
  • Table 7
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section